New cancer clinical trial: Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer
Published on: October 03, 2017 at 10:00AM
Condition: Thyroid Cancer
Interventions: Drug: Apatinib; Radiation: Intensity modulated radiation therapy
Sponsor: Xiayun He, MD
Recruiting
http://ift.tt/2knhnOW
More Stories
‘My 401k Misses You’: Black Woman Pumped To Meet Donald Trump In Philadelphia – July 18, 2023 at 04:56PM
Energy Provider Warns of Impending ‘Crisis,’ ‘Blackout Conditions’ Driven By Biden Plans – July 18, 2023 at 04:20PM
Dog starts barking at cows crossing a bridge, so the cows stop to have a look. – July 17, 2023 at 02:27PM